new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Sanofi Pasteur
Sanofi Pasteur Sa
Sanofi Pasteur Biologics Llc
Sanofi Pasteur Biologics Co
Sanofi Pasteur Limited
Sanofi Pasteur Inc
Sanofi Pasteur Vaxdesign Corporation
Sanofi Pasteur Ltd
Sanofi Pasteur S a
Sanofi Pasteur Limited sanofi Pasteur Limitee
Sanofi Pasteur Vaxdesign Corp
Sanofi Pasteur_20100121
  

Sanofi Pasteur patents

Recent patent applications related to Sanofi Pasteur. Sanofi Pasteur is listed as an Agent/Assignee. Note: Sanofi Pasteur may have other listings under different names/spellings. We're not affiliated with Sanofi Pasteur, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "S" | Sanofi Pasteur-related inventors




Date Sanofi Pasteur patents (updated weekly) - BOOKMARK this page
04/07/16Induction of cross-reactive cellular response against rhinovirus antigens
10/01/15Vaccination against japanese encephalitis, measles, mumps and rubella
09/24/15Vaccine compositions for prevention against dengue virus infection
09/17/15Method of storing a vaccine containing an aluminum adjuvant
07/16/15Vaccine compositions
07/09/15Production of infectious influenza viruses
06/18/15Method for producing haemophilus influenzae type b antigens
01/29/15Dengue serotype 2 attenuated strain
12/18/14Method for formulating a vaccine containing at least two antigens capable of adsorbing onto aluminium oxyhydroxide
08/21/14Vaccine composition with aluminium hydroxide nanoparticles
06/26/14Immuno-adjuvant emulsion
02/06/14Stabilizing excipient for inactivated whole virus vaccine
01/31/13Stabilizer and vaccine composition comprising one or more live attenuated flaviviruses
06/21/12Meningococcal vaccine based on lipooligosaccharide (los) and neisseria meningitidis protein
04/19/12Method of storing a vaccine containing an aluminum adjuvant
01/05/12Enterovirus vaccines for preventing or treating type 1 diabetes (i)
01/05/12Enterovirus vaccines for preventing and treating type 1 diabetes (ii)
01/05/12Enterovirus vaccines for preventing or treating type 1 diabetes (iii)
08/04/11Immunization compositions and methods
04/07/11Stabilizing excipient for inactivated whole virus vaccine
01/20/11Method for adjuvanting lipopolysaccharide (lps) of gram-negative bacteria
12/30/10Meningococcal vaccine based on lipooligosaccharide (los) originating from modified neisseria meningitidis strains of immunotype l6
11/18/10Detoxification lipopolysaccharide (lps) or lipid a of gram-negative bacteria
10/14/10Method for purifying the rabies virus
09/30/10Immunostimulant composition comprising at least one toll-like receptor 7 or toll-like receptor 8 agonist and a toll-like receptor 4 agonist
05/06/10Polypeptide recognized by anti hiv-1 gp41 antibodies isolated from highly hiv-1 exposed, non infected women
01/21/10Stabilizer and vaccine composition comprising one or more live attenuated flaviviruses
09/17/09Process for stabilizing an adjuvant containing vaccine composition
04/23/09Vaccine composition for the prevention of cmv infection
04/09/09Flu virus hemagglutinin specific monoclonal antibodies
03/26/09Method for producing the flu virus
01/21/10Stabilizer and vaccine composition comprising one or more live attenuated flaviviruses
01/28/16Automated imaging and analysis of the hemagglutination inhibition assay (hai)
04/23/15Fluorescent neutralization and adherence inhibition assays
09/04/14Methods for testing an immune response using cultures of t cells, b cells, dendritic cells and follicular dendritic cells
05/29/14Artificial tissue constructs comprising alveolar cells and methods for using the same
03/01/12Methods for testing an immune response using cultures of t cells, b cells and dendritic cells
11/03/11Methods for assaying responses to vaccines
10/13/11Methods of evaluating an immune response to an antigen
07/09/15Methods of using ceo2 and tio2 nanoparticles in modulation of the immune system
06/21/12In vitro urogenital co-culture models
01/12/12Methods of evaluating a test agent in a diseased cell model
08/18/16Process for stabilizing an adjuvant containing vaccine composition
02/18/16Meningococcal vaccine based on lipooligosaccharide (los) originating from modified neisseria meningitidis strains of immunotype l6
08/06/15Method for purifying the rabies virus
01/08/15Heating device for rotary drum freeze-dryer
12/25/14Rotary drum for use in a vacuum freeze-dryer
08/07/14Immunization compositions and methods
06/05/14Process for stabilizing an adjuvant containing vaccine composition
12/15/11Process for preparing prophyrin derivatives, such as protoprophyrin (ix) and synthesis intermediates
08/25/11Dengue chimeric viruses
06/23/11Process for culturing adherent cells
03/03/11Type 5 and type 8 capsular polysaccharides of overproducing s. aureus strains
12/30/10Method for the production of overproducing staphylococcus aureus strains
10/28/10Method of immunization against the 4 dengue serotypes
09/23/10Method of immunization against the 4 serotypes of dengue fever
09/02/10Method of immunization against the 4 dengue serotypes
08/26/10Dengue chimeric viruses
12/22/16Immunogenic compositions
08/25/11Self-replicating vector lacking an antibiotic-resistance gene
05/19/11Multivalent vaccine composition with mixed carrier
11/22/12Monoclonal antibodies and uses thereof
09/22/11System and process for producing multi-component biopharmaceuticals
02/24/11Monoclonal antibodies and uses thereof
01/06/11Immunogenic pcpa polypeptides and uses thereof
Patent Packs
04/13/17Assay for diagnosing streptococcus pneumoniae
03/09/17Immunological compositions
12/22/16Immunogenic compositions
06/02/16Vaccines using high-dose cytokines
03/03/16System and process for producing mulit-component biopharmaceuticals
02/04/16Methods for purifying pertussis toxin and peptides useful therefor
12/10/15Method of inducing and/or enhancing an immune response to tumor antigens
11/05/15Methods for assessing immunogenicity
06/04/15Herpesvirus compositions and related methods
01/15/15Composition for immunization against streptococcus pneumoniae
11/27/14Assay for diagnosing streptococcus pneumoniae
12/26/13Immunogenic compositions
11/04/10Streptococcus pneumoniae proteins and nucleic acid molecules
11/12/09Chlamydia omp antigen
08/27/09Omp p6 vaccine for treating and preventing chlamydia infection
Patent Packs
09/11/14Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics
03/28/13Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics
06/11/09Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics
05/05/16Compositions and methods for immunizing against c. difficile
02/18/16Toxoid, compositions and related methods
02/04/16Toxoid, compositions and related methods
01/07/16Multivalent meningococcal polysaccharide-protein conjugate vaccine
06/25/15Multivalent meningococcal polysaccharide-protein conjugate vaccine
10/16/14Multivalent meningococcal polysaccharide-protein conjugate vaccine
07/11/13Multivalent meningococcal polysaccharide-protein conjugate vaccine
12/06/12Immunological compositions for hiv
03/05/09Immunological compositions
02/26/09Apparatus and harvesting biologics from eggs
11/17/16Purification of herpes virus
11/03/16Pharmaceutical compositions containing clostridium difficile toxoids a and b
10/06/16Immunization against clostridium difficile disease
03/10/16Antibodies against clostridium difficile toxins and methods of using the same
02/25/16Methods and compositions for increasing toxin production
02/18/16Alkylated influenza vaccines
06/04/15Herpesvirus compositions and related methods
01/29/15Purification of flaviviruses
01/29/15Immunization against clostridium difficile disease
01/22/15Flavivirus vaccines
01/01/15Purification of herpes virus
06/12/14Novel neutralizing immunogen (nimiv) of rhinovirus and its uses for vaccine applications
09/19/13Replication-defective flavivirus vaccines and vaccine vectors
07/25/13Flavivirus vaccines
07/11/13Immunization against clostridium difficile disease
04/18/13Tetravalent dengue vaccines
11/15/12Recombinant flavivirus vaccines
Social Network Patent Pack
08/09/12Vaccines against japanese encephalitis virus and west nile virus
05/24/12Replication-defective flavivirus vaccine vectors against respiratory syncytial virus
10/20/11Methods and compositions for increasing toxin production
08/18/11Compositions and methods for the production of alpha-herpesviruses
06/09/11Replication-defective flavivirus vaccines and vaccine vectors
05/12/11Influenza b vaccines
04/21/11Recombinant rhinovirus vectors
02/24/11Pharmaceutical compositions containing clostridium difficile toxoids a and b
01/20/11Chimeric flavivirus vectors
11/25/10Novel neutralizing immunogen (nimiv) of rhinovirus and its use for vaccine applications
Patent Packs
10/07/10Flavivirus vaccine vector against influenza virus
09/30/10Stabilization of vaccines by lyophilization
09/23/10Recombinant rhinovirus vectors
07/22/10Construction of recombinant virus vaccines by direct transposon-mediated insertion of foreign immunologic determinants into vector virus proteins
04/08/10West nile virus vaccine
02/11/10Recombinant bicistronic flavivirus vectors







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Sanofi Pasteur in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Sanofi Pasteur with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';